HSC01
clear graphic
clear graphic

Physicians, researchers learn about new agents in oncology

Posted: Tuesday, March 19, 2013 · Volume: XLVI · Issue: 6

Share |


Guest faculty for the conference included (left to right) Craig Reynolds, M.D., development chair in lung cancer at U.S. Oncology Research; Ken Anderson, M.D., Kraft Family Professor of Medicine at Harvard Medical School; and Dan Von Hoff, M.D., FACP, physician-in-chief and distinguished professor in the Translational Research Division at Translational Genomics Research Institute in Phoenix, Ariz.
clear graphic
Guest faculty for the conference included (left to right) Craig Reynolds, M.D., development chair in lung cancer at U.S. Oncology Research; Ken Anderson, M.D., Kraft Family Professor of Medicine at Harvard Medical School; and Dan Von Hoff, M.D., FACP, physician-in-chief and distinguished professor in the Translational Research Division at Translational Genomics Research Institute in Phoenix, Ariz. clear graphic

Email Printer Friendly Format
 

By Rosanne Fohn

One hundred thirty physicians and oncology researchers recently attended the “Practical Applications of New Agents in Oncology” conference held Feb. 22-23.

The conference was hosted by the Institute for Drug Development, part of the Cancer Therapy & Research Center at the UT Health Science Center San Antonio. It was held at the Greehey Children’s Cancer Research Institute.

The meeting focused on new anticancer drugs and related therapeutics that have been approved in the past few years, as well as those likely to be approved in the near future.

“We were very pleased with the turnout and interest in the conference by physicians from the surrounding area as well as from outside of the State,” said Steve Weitman, M.D., Ph.D., director of the Institute for Drug Development and the AT&T Distinguished Chair of Drug Development.

Tyler Curiel, M.D., M.P.H., professor of medicine in the Division of Hematology/Oncology, was one of several UT Health Science Center San Antonio faculty members who gave presentations at the conference.
clear graphic
Tyler Curiel, M.D., M.P.H., professor of medicine in the Division of Hematology/Oncology, was one of several UT Health Science Center San Antonio faculty members who gave presentations at the conference. clear graphic

 

“The conference covered some of the most important new drugs and therapies available for brain tumors, multiple myeloma, pancreatic cancer, ovarian and breast cancer, lung cancer, sarcoma, and leukemia and lymphoma,” Dr. Weitman said. “We also discussed how these new drugs could interact with other medications that cancer patients may be taking as well as the importance of physical activity in the treatment of cancer.”

Slides from the presentations will be available on the CTRC website through March 31.

 
bottom bar

»printer friendly format...
»view more articles by issue#...
»search articles by keywords...
Arrow - to top
HSC Alert - Sign up today
Calendar of Events
Tell Us Your Story Idea
Submission Guidelines
Arrow - to top